Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Recruiting Observational Study
ADPKD
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 18
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Children's Hospital of Philadelphia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the last decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at-risk for of ADPKD are lacking. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Demonstration of ADPKD by clinical information, imaging studies, biopsy, autopsy, or genetic testing. Exclusion Criteria: * Patients with Autosomal Recessive Polycystic Kidney disease (ARPKD), urinary tract malformations or major congenital anomalies of other systems suggest…
Contacts

Jasmine Jaber, MS

267-425-5325

jaberj2@chop.edu

CONTACT